Characterization of acinetobacter baumannii clinical isolates carrying blaOXA-23 carbapenemase and 16S rRNA methylase armA genes in Yemen

Microbial Drug Resistance

Volumn 20, Issue 6, 2014, Pages 604-609

  Bakour, Sofiane ^a,b   Alsharapy, Samer Ahmed ^a,c   Touati, Abdelaziz ^a   Rolain, Jean Marc ^b  

^a UNIVERSITY OF BEJAIA   (Algeria)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Al Thawra Hospital   (Yemen)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOGLYCOSIDE MODIFYING ENZYME; BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CARBAPENEMASE; CIPROFLOXACIN; IMIPENEM; METHYLTRANSFERASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RNA 16S; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; TRANSFER RNA METHYLTRANSFERASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARMA GENE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLAOXA 23 GENE; BLAOXA 51 GENE; CASE REPORT; GENE MUTATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; YEMEN; ACINETOBACTER INFECTIONS; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PROCEDURES;

ACINETOBACTER BAUMANNII; ARMA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; RNA, RIBOSOMAL, 16S; TRNA METHYLTRANSFERASES; YEMEN;

EID: 84907280579     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2014.0018     Document Type: Article

References (38)

1. Al-Shamahy, H.A., A.A. Sabrah, A.B. Al-Robasi, and S.M. Naser. 2012. Types of Bacteria associated with Neonatal Sepsis in Al-Thawra University Hospital, Sana'a, Yemen, and their antimicrobial profile. Sultan. Qaboos. Univ. Med. J. 12:48-54.
2. Al-Sweih, N.A., M. Al-Hubail, and V.O. Rotimi. 2012. Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait. J. Infect. Public Health 5:102-108.
3. Alsultan, A.A., B.A. Evans, E.A. Elsayed, S.I. Al-Thawadi, A.Y. Al-Taher, S.G. Amyes, A.M. Al-Dughaym, and A. Hamouda. 2013. High frequency of carbapenem-resistant Acinetobacter baumannii in patients with diabetes mellitus in Saudi Arabia. J. Med. Microbiol. 62:885-888.
4. Aly, M., H.T. Tayeb, S.M. Al Johani, E.J. Alyamani, F. Aldughaishem, I. Alabdulkarim, and H.H. Balkhy. 2014. Genetic diversity of OXA-51-like genes among multidrugresistant Acinetobacter baumannii in Riyadh, Saudi Arabia. Eur. J. Clin. Microbiol. Infect. Dis [Epub ahead of print]; DOI: 10.1007/s10096-014-2068-0.
5. Bakour, S., M. Kempf, A. Touati, A.A. Ait, D. Haouchine, F. Sahli, and J.M. Rolain. 2012. Carbapenemaseproducing Acinetobacter baumannii in two university hospitals in Algeria. J. Med. Microbiol. 61:1341-1343.
6. Bonnin, R.A., V.O. Rotimi, H.M. Al, E. Gasiorowski, S.N. Al, P. Nordmann, and L. Poirel. 2013. Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait. Antimicrob. Agents Chemother. 57:183-188.
7. Coelho, J., N. Woodford, M. Afzal-Shah, and D. Livermore. 2006. Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob. Agents Chemother. 50:756-758.
8. Da Silva, G.J., N. Mendonca, G. Batista, and A. Duarte. 2010. Sequence types of Portuguese carbapenem-resistant Acinetobacter baumannii isolates collected over 10 years. J. Antimicrob. Chemother. 65:2254-2256.
9. Dijkshoorn, L., A. Nemec, and H. Seifert. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5:939-951.
10. Doi, Y. and Y. Arakawa. 2007. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin. Infect. Dis. 45:88-94.
11. Dortet, L., L. Poirel, Y.F. Al, and P. Nordmann. 2012. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman. Clin. Microbiol. Infect. 18:E144-E148.
12. Falagas, M.E., S.K. Kasiakou, and A. Michalopoulos. 2005. Treatment of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii pneumonia. J. Cyst. Fibros. 4:149-150.
13. Ghazawi, A., A. Sonnevend, R.A. Bonnin, L. Poirel, P. Nordmann, R. Hashmey, T.A. Rizvi, B. Hamadeh, and T. Pal. 2012. NDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates. Clin. Microbiol. Infect. 18:E34-E36.
14. Gogou, V., S. Pournaras, M. Giannouli, E. Voulgari, E.T. Piperaki, R. Zarrilli, and A. Tsakris. 2011. Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-2009). J. Antimicrob. Chemother. 66:2767-2772.
15. Jamal, W., V.O. Rotimi, M.J. Albert, F. Khodakhast, E.E. Udo, and L. Poirel. 2012. Emergence of nosocomial New Delhi metallo-beta-lactamase-1 (NDM-1)-producing Klebsiella pneumoniae in patients admitted to a tertiary care hospital in Kuwait. Int. J. Antimicrob. Agents 39: 183-184.
16. Jeong, S.H., I.K. Bae, K.O. Park, Y.J. An, S.G. Sohn, S.J. Jang, K.H. Sung, K.S. Yang, K. Lee, D. Young, and S.H. Lee. 2006. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J. Microbiol. 44:423-431.
17. Karah, N., A. Sundsfjord, K. Towner, and O. Samuelsen. 2012. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist. Updates. 15:237-247.
18. Kempf, M., and J.M. Rolain. 2012. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int. J. Antimicrob. Agents 39:105-114.
19. Lee, K., C.K. Kim, D. Yong, S.H. Jeong, J.H. Yum, Y.H. Seo, J.D. Docquier, and Y. Chong. 2010. Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli. J. Microbiol. Methods 83:149-152.
20. Mendes, R.E., K.A. Kiyota, J. Monteiro, M. Castanheira, S.S. Andrade, A.C. Gales, A.C. Pignatari, and S. Tufik. 2007. Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex realtime PCR assay and melt curve analysis. J. Clin. Microbiol. 45:544-547.
21. Mesli, E., M. Berrazeg, M. Drissi, S.N. Bekkhoucha, and J.M. Rolain. 2013. Prevalence of carbapenemase-encoding genes including New Delhi metallo-beta-lactamase in Acinetobacter species, Algeria. Int. J. Infect. Dis. 17:e739-e743.
22. Motaouakkil, S., B. Charra, A. Hachimi, H. Nejmi, A. Benslama, N. Elmdaghri, H. Belabbes, and M. Benbachir. 2006. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J. Infect. 53:274-278.
23. Mugnier, P., L. Poirel, M. Pitout, and P. Nordmann. 2008. Carbapenem-resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates. Clin. Microbiol. Infect. 14:879-882.
24. Mugnier, P.D., K.M. Bindayna, L. Poirel, and P. Nordmann. 2009. Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain. J. Antimicrob. Chemother. 63:1071-1073.
25. Neonakis, I.K., D.A. Spandidos, and E. Petinaki. 2011. Confronting multidrug-resistant Acinetobacter baumannii: a review. Int. J. Antimicrob. Agents 37:102-109.
26. Opazo, A., L. Vali, O.K. Al, A.A. Dashti, and S.G. Amyes. 2014. Novel genetic structure harbouring bla in ceftazidime-resistant Acinetobacter baumannii isolated from Kuwait. Int. J. Antimicrob. Agents 43:383-384.
27. Pajand, O., Z. Hojabri, M.R. Nahaei, F. Hajibonabi, T. Pirzadeh, M. Aghazadeh, T. Fasciana, C. Bonura, and C. Mammina. 2014. In vitro activities of tetracyclines against different clones of multidrug-resistant Acinetobacter baumannii isolates from two Iranian hospitals. Int. J. Antimicrob. Agents 43:476-478.
28. Park, S., K.M. Lee, Y.S. Yoo, J.S. Yoo, J.I. Yoo, H.S. Kim, Y.S. Lee, and G.T. Chung. 2011. Alterations of gyrA, gyrB, and parC and activity of efflux pump in fluoroquinolone-resistant Acinetobacter baumannii. Osong Public Health Res. Perspect. 2:164-170.
29. Peleg, A.Y., H. Seifert, and D.L. Paterson. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582.
30. Peymani, A., P.G. Higgins, M.R. Nahaei, S. Farajnia, and H. Seifert. 2012. Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran. Int. J. Antimicrob. Agents 39: 526-528.
31. Poirel, L., M.Z. Al, R.F. Al, S. Bernabeu, and P. Nordmann. 2011. NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J. Antimicrob. Chemother. 66:304-306.
32. Roca, I., P. Espinal, X. Vila-Farres, and J. Vila. 2012. The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace. Front. Microbiol. 3:148.
33. Seng, P., M. Drancourt, F. Gouriet, S.B. La, P.E. Fournier, J.M. Rolain, and D. Raoult. 2009. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Infect. Dis. 49:543-551.
34. Shibl, A., M. Al-Agamy, Z. Memish, A. Senok, S. A. Khader, and A. Assiri. 2013. The emergence of OXA-48-and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia. Int. J. Infect. Dis. 17:e1130-e1133.
35. Sonnevend, A., A. Ghazawi, M.N. Al, M. Pitout, M.B. Hamadeh, R. Hashmey, S.K. Girgis, F.A. Sheikh, H.M. Al, N. Nagelkerke, and T. Pal. 2013. Characteristics of epidemic and sporadic strains of Acinetobacter baumannii isolated in Abu Dhabi hospitals. J. Med. Microbiol. 62: 582-590.
36. Touati, M., S.M. Diene, A. Racherache, M. Dekhil, A. Djahoudi, and J.M. Rolain. 2012. Emergence of blaOXA-23 and blaOXA-58 carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii isolates from University Hospital of Annaba, Algeria. Int. J. Antimicrob. Agents 40:89-91.
37. Zarrilli, R., S. Pournaras, M. Giannouli, and A. Tsakris. 2013. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int. J. Antimicrob. Agents 41:11-19.
38. Zowawi, H.M., H.H. Balkhy, T.R. Walsh, and D.L. Paterson. 2013. beta-Lactamase production in key gramnegative pathogen isolates from the Arabian Peninsula. Clin. Microbiol. Rev. 26:361-380.